iShares Biotechnology ETF (SNSE:IBB)
Chile · Delayed Price · Currency is CLP · Price in USD 174.00
0.00 (0.00%)
At close: Apr 2, 2026
23.26% (1Y)
| Assets | n/a |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Dividend (ttm) | 244.21 |
| Dividend Yield | 0.15% |
| Ex-Dividend Date | Dec 16, 2025 |
| Payout Frequency | Semi-Annual |
| Payout Ratio | n/a |
| 1-Year Return | +23.47% |
| Volume | n/a |
| Open | n/a |
| Previous Close | 174.00 |
| Day's Range | n/a |
| 52-Week Low | 126.99 |
| 52-Week High | 174.00 |
| Beta | n/a |
| Holdings | n/a |
| Inception Date | Feb 5, 2001 |
About IBB
iShares Biotechnology ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. It invests in public equity markets of the United States. It invests in stocks of companies operating across biotechnology sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the NYSE Biotechnology Index, by using representative sampling technique. iShares Biotechnology ETF was formed on February 5, 2001 and is domiciled in the United States.
Stock Exchange Santiago Stock Exchange
Ticker Symbol IBB
Performance
IBB had a total return of 23.47% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.70%.
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | 167.59052 CLP | Dec 19, 2025 |
| Sep 16, 2025 | 78.57079 CLP | Sep 19, 2025 |
| Mar 18, 2025 | 111.01564 CLP | Mar 21, 2025 |
| Dec 17, 2024 | 61.64443 CLP | Dec 20, 2024 |
| Sep 25, 2024 | 182.93453 CLP | Sep 30, 2024 |
| Mar 21, 2024 | 122.38679 CLP | Mar 27, 2024 |